Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors with FGFR2 Alterations [Phase 1]
A Phase 1 study evaluating KNT-0916 in unresectable or metastatic solid tumors with FGFR2 alterations. The trial status is not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors [EARLY_Phase 1]
A microdose Phase 1 study of the radiopharmaceutical TTX-MC138-NODAGA-Cu64 in patients with advanced solid tumors has completed. The sponsor…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 study of ADA-011 for advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating safety and preliminary activity of KT-253 in adults with high-grade myeloid malignancies, acute lymphoblas…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating palmitoylethanolamide (PEA) for relief of chemotherapy-induced peripheral neuropathy; study is active-not-recruitin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study results assess the clinical and immunologic effects of ALT-803 in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Clinical Study of ASN-3186 in Patients with Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update on ASN-3186 for patients with advanced solid tumors in Phase 1/2, sponsored by Jiangsu Yahong Meditech Co., Ltd (Asier…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors [Phase 1]
A Phase 1 dose-escalation study of PF-06939999 in participants with advanced or metastatic solid tumors was terminated, with results posted …
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of DSP107 alone and in combination with atezolizumab. The study targets patients with a…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of KN510 and KN713 in patients with advanced solid tumors has comp…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Trial Comparing Parenteral Nutrition (PN) Using Eurotubes® vs. 2/3-chamber Bags in Subjects With Solid Tumors Requiring PN (PEKANNUSS)
A clinical trial comparing Eurotubes parenteral nutrition to 2/3-chamber bags in patients with solid tumors was terminated, with no results …
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 [Phase 1]
A Phase 1 trial assessing the safety, tolerability, and pharmacokinetics of BAT1006 in patients with advanced solid tumors has been complete…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors [Phase 1, Phase 2]
Clinical trial evaluating idasanutlin in combination with chemotherapy or venetoclax in pediatric and young adult relapsed/refractory acute …
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit [Phase 1]
A completed Phase 1 dose-escalation study of BI 2536 BS in patients with advanced solid tumors evaluated safety, tolerability, and prelimina…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: A Retro-/Prospective, Non-interventional, Cohort Study in Adult Patients With Locally Advanced or Metastatic Tumors With a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion, Treated With Larotrectinib
This is a completed non-interventional cohort study in adults with NTRK-fusion solid tumors treated with larotrectinib.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes RVU120 (SEL120) being tested in Phase 1/2 for patients with advanced, relapsed or refractory solid tumo…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 dose-escalation study of JAB-3068, an SHP2 inhibitor, in adults with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: AMG 404 in Patients With Advanced Solid Tumors [Phase 1]
Amgen reports Phase 1 results for AMG 404 in patients with advanced solid tumors; the study is completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating CD70-targeted CAR-NKT cell therapy for advanced malignant solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT [Phase 1, Phase 2]
Update on a Phase I/IIa PET imaging trial of 68GaNOTA-Anti-MMR-VHH2 for malignant solid tumors, including breast cancer and melanoma; the st…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C) [Phase 2]
Phase 2 MATCH subprotocol Z1C evaluates palbociclib in cancers with CDK4/CDK6 amplification; results have been posted and the trial is curre…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A) [Phase 2]
Phase 2 MATCH subprotocol evaluating afatinib for cancers with EGFR genetic alterations; results have been posted and the trial is active bu…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas [Phase 1]
Phase 1 trial of the indenoisoquinoline LMP744 in adults with relapsed solid tumors and lymphomas has completed, with results posted in Dece…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors [Phase 1]
This update describes a Phase 1 study evaluating a triplet chemotherapy regimen—liposomal irinotecan combined with temozolomide and vincrist…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA) [Phase 1]
Phase 1 PANAMA trial evaluating a dual NAMPT/PAK4 inhibitor in patients with solid tumors or non-Hodgkin lymphoma was terminated, with resul…